Tag: Blood Disorders
American Society of Hematology, Dec. 7 to 10
COVID-19 Mortality Higher for Leukemia, Myelodysplastic Syndrome Patients
However, risk for hospitalization no higher for COVID-19 in these patients
FDA Approves Hympavzi for Hemophilia
Approval is for prophylactic treatment and targets protein in the blood clotting process
14 Percent of U.S. Adults Meet Criteria for Absolute Iron Deficiency
Among those without anemia, heart failure, CKD, current pregnancy, 11 and 15 percent have absolute and functional iron deficiency
Pomalidomide Efficacious in Hereditary Hemorrhagic Telangiectasia
Significant reduction seen in epistaxis severity with pomalidomide treatment for patients with HHT
Iron Deficiency Common, Often Persistent
41.9 percent of patients had resolution within three years of diagnosis, with median time to resolution of 1.9 years
Mentorship Program in Classical Hematology Facilitates Career Development
Perceiving that the mentor was a good match linked to positive impact on confidence, career development, professional identity
No Association Found for Autoimmune Disease, Monoclonal Gammopathy
However, autoimmune disease diagnoses linked to prior clinical diagnosis of monoclonal gammopathy of undetermined significance
Recombinant ADAMTS13 Effective, Safe in Congenital Thrombotic Thrombocytopenic Purpura
Treatment had few adverse events and increased ADAMTS13 activity versus standard therapy
Review Explores Cutaneous Manifestations of Myelodysplastic Syndrome
Common manifestations include neutrophilic dermatoses, vasculitis, granulomatous, connective tissue disease
